id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0719-0002,FDA,FDA-2013-N-0719,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products,Notice,30 Day Proposed Information Collection,2013-12-02T05:00:00Z,2013,12,2013-12-02T05:00:00Z,2014-01-03T04:59:59Z,2013-12-03T01:11:39Z,2013-28735,0,0,09000064814a2106
FDA-2013-N-0719-0001,FDA,FDA-2013-N-0719,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products,Notice,60 Day Proposed Information Collection,2013-06-21T04:00:00Z,2013,6,2013-06-21T04:00:00Z,2013-08-21T03:59:59Z,2013-12-03T03:04:24Z,2013-14812,0,0,09000064813375bd